Amarin Corp Plcuk (AMRN) Revenue (2013 - 2026)
Amarin Corp Plc\Uk (AMRN) posted quarterly Revenue of $42.2 million for Q2 2026, down 41.97% year-over-year from $72.7 million in Q2 2025, and down 6.47% quarter-over-quarter from $45.1 million in Q1 2026.
Amarin Corp Plcuk (AMRN) Revenue (2013 - 2026) Analysis & Trends
Amarin Corp Plc\Uk (AMRN) has reported Revenue for 14 consecutive years, with $42.2 million the latest figure, recorded in Q2 2026.
- In Q2 2026, Revenue fell 41.97% year-over-year to $42.2 million; the TTM figure through Jun 2026 stood at $186.2 million (down 15.1% YoY), while the FY2025 annual figure was $213.6 million, down 6.55% from the prior year.
- Revenue declined to $42.2 million in Q2 2026 per AMRN's latest filing, from $45.1 million in the prior quarter.
- Across five years, Revenue topped out at $94.6 million in Q1 2022 and bottomed at $42.0 million in Q1 2025.
- Historically, Revenue has averaged $67.0 million across 5 years, with a median of $66.8 million in 2023.
- Annual changes were most pronounced in 2025 — Revenue climbed 17.43% — and 2026, when it plunged 41.97%.
- Amarin Corp Plc\Uk's Revenue stood at $90.2 million in 2022, then declined by 17.21% to $74.7 million in 2023, then slipped by 16.61% to $62.3 million in 2024, then fell by 21.0% to $49.2 million in 2025, then decreased by 14.24% to $42.2 million in 2026.
- Business Quant data shows AMRN's Revenue at $42.2 million in Q2 2026, $45.1 million in Q1 2026, and $49.2 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.88 Bn | 625.12 Bn | 17.26 Bn | 25.31 Bn |
| 2 | AbbVie | 463.46 Bn | 456.89 Bn | 12.70 Bn | 16.99 Bn |
| 3 | Merck | 367.92 Bn | 360.78 Bn | 12.21 Bn | 16.61 Bn |
| 4 | Novartis Ag | 297.71 Bn | 290.02 Bn | 11.24 Bn | 14.41 Bn |
| 5 | Astrazeneca | 255.55 Bn | 250.65 Bn | 12.86 Bn | 15.38 Bn |
| 6 | Amgen | 234.52 Bn | 220.53 Bn | 7.24 Bn | 10.05 Bn |
| 7 | Gilead Sciences | 178.22 Bn | 175.04 Bn | 6.22 Bn | 7.80 Bn |
| 8 | Pfizer | 158.57 Bn | 146.88 Bn | 10.94 Bn | 15.03 Bn |
| 9 | Gsk | 105.32 Bn | 101.15 Bn | 8.24 Bn | 11.28 Bn |
| 10 | Amarin Corp Plcuk | 5.88 Bn | 5.56 Bn | 14.99 Mn | 42.21 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 42.21 Mn |
| Mar 31, 2026 | 45.13 Mn |
| Dec 31, 2025 | 49.22 Mn |
| Sep 30, 2025 | 49.67 Mn |
| Jun 30, 2025 | 72.74 Mn |
| Mar 31, 2025 | 42.02 Mn |
| Dec 31, 2024 | 62.31 Mn |
| Sep 30, 2024 | 42.30 Mn |
| Jun 30, 2024 | 67.49 Mn |
| Mar 31, 2024 | 56.52 Mn |
| Dec 31, 2023 | 74.71 Mn |
| Sep 30, 2023 | 66.06 Mn |
| Jun 30, 2023 | 80.17 Mn |
| Mar 31, 2023 | 85.98 Mn |
| Dec 31, 2022 | 90.25 Mn |
| Sep 30, 2022 | 89.88 Mn |
| Jun 30, 2022 | 94.44 Mn |
| Mar 31, 2022 | 94.63 Mn |
| Dec 31, 2021 | 144.49 Mn |
| Sep 30, 2021 | 142.04 Mn |